Form D — Typewriter Therapeutics, Inc.
0002156390-26-000001 · filed Sep 21, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- $56,299,999
- Reported amount sold
- $56,299,999
- Minimum investment
- $0
- Investors
- 6
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- Typewriter Therapeutics, Inc.
- CIK
- 2156390
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2022
- Address
- 238 MAIN STREET, OFFICE 2162
CAMBRIDGE, MA 02142 - Phone
- 609-923-9289
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Matthew Stanton · Executive OfficerCambridge, MA Find on LinkedIn ↗
-
Kenneth Horne · DirectorCambridge, MA Find on LinkedIn ↗
-
Laura Tadvalkar · DirectorCambridge, MA Find on LinkedIn ↗
-
Mikael Dolston · DirectorCambridge, MA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗